NPS MedicineWise
NPS MedicineWise is an independent, not-for-profit, evidence-based and consumer-centred organisation, working to improve the way health technologies, medicines and medical tests are prescribed and used.
Medicine Finder: Search medicine by active ingredient or brand …
Medicine Finder: Learn more about many types of medicines that are prescribed or recommended for treatment. Learn more about getting the most from your medicines.
About us - NPS MedicineWise
Feb 2, 2023 · NPS MedicineWise was established in 1998 as the National Prescribing Service (NPS) Limited. Through two decades of continuous national leadership and services provided in the health sector, NPS MedicineWise committed to supporting quality use of medicines to improve health decisions and health and economic outcomes in Australia.
Consumer information about medicines and medical tests. - NPS …
It is common for medicine misadventure to be a cause of poisoning in little ones. It's really important to read the label, to make sure that it is the correct modification for that child and also, so they know what the active ingredient is.
For health professionals - NPS MedicineWise
Therapeutic Guidelines Limited was recently selected by the Department of Health and Aged Care as the new publisher of Australian Prescriber. All volumes of the journal including new issues can be accessed in the website australianprescriber.tg.org.au
Consumer medicine information (CMI) explained - NPS …
Feb 19, 2017 · Consumer medicine information (CMI) is designed to inform you about prescription and pharmacist-only medicines. CMI leaflets are written by pharmaceutical companies, who have to follow government guidelines about what to include and ensure their information is accurate, unbiased and easy to understand.
Medicines for type 2 diabetes: 2022 update - NPS MedicineWise
Metformin is the usual first-choice medicine for people with type 2 diabetes. It is started either at diagnosis or after 2–3 months of lifestyle modifications depending on each patient’s clinical circumstances. 1, 2, 4, 6 Metformin has been shown to reduce diabetes- related complications and all-cause mortality in overweight patients with type 2 diabetes. 7 Starting doses should be …
Prescribing Competencies Framework - NPS MedicineWise
Apr 26, 2021 · The Prescribing Competencies Framework describes the competencies that health professionals require to prescribe medicines judiciously, appropriately, safely and effectively in the Australian healthcare system The Australian Health Practitioner Regulation Agency (AHPRA) has been contracted by the ...
Medicines for chronic kidney disease: A practical guide - NPS …
For all people with CKD, prescribe an ACE inhibitor or ARB, up-titrated to the maximum tolerated dose. Add an SGLT2 inhibitor (dapagliflozin), and blood pressure-lowering, lipid-lowering and glucose-lowering medicines, as determined by clinical factors such as whether the person is meeting a therapeutic target.
Blood pressure - NPS MedicineWise
Persistently high blood pressure (BP) is a major modifiable risk factor for stroke and coronary heart disease (CHD). To account for the large number of possible risk factors and the potential interplay between them, local and international guidelines for primary CVD prevention base management on absolute CVD risk rather than targeting isolated risk factors.